Sources | Names Used |
---|---|
CTRPv2 | doxorubicin:navitoclax (2:1 mol/mol) |
PharmacoGx | doxorubicin:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZNF606 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | TP73 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
mRNA | KMT2E | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
mRNA | GTF3C6 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
mRNA | POLR1D | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | AL358852.1 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
mRNA | ZNF142 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | BOLA2 | CTRPv2 | pan-cancer | AAC | -0.14 | 2e-05 |
mRNA | TRIOBP | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
mRNA | FBXO41 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-05 |